Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Bristol-Myers Squibb
M.D. Anderson Cancer Center
University of California, San Diego
Immodulon Therapeutics Ltd
NeoImmuneTech
University of Michigan Rogel Cancer Center
OHSU Knight Cancer Institute
SQZ Biotechnologies
The Methodist Hospital Research Institute
Nektar Therapeutics
Brown University
WindMIL Therapeutics
AIO-Studien-gGmbH
Odonate Therapeutics, Inc.
UNC Lineberger Comprehensive Cancer Center
Mereo BioPharma
MultiVir, Inc.